Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 A Bonaventura, A Vecchié, L Dagna, K Martinod, DL Dixon, ... Nature Reviews Immunology 21 (5), 319-329, 2021 | 763 | 2021 |
The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome LS Sperling, JI Mechanick, IJ Neeland, CJ Herrick, JP Després, ... Journal of the American College of Cardiology 66 (9), 1050-1067, 2015 | 326 | 2015 |
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of … Writing Committee Members, SS Virani, LK Newby, SV Arnold, V Bittner, ... Journal of the American College of Cardiology 82 (9), 833-955, 2023 | 214 | 2023 |
Collaborative drug therapy management and comprehensive medication management―2015 American College of Clinical Pharmacy, SE McBane, AL Dopp, A Abe, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (4 …, 2015 | 197 | 2015 |
Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial) BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ... Circulation: Heart Failure 10 (11), e004373, 2017 | 186 | 2017 |
Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ... Journal of the American Heart Association 6 (5), e005686, 2017 | 185 | 2017 |
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 183 | 2020 |
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 149 | 2018 |
Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ... Journal of cardiovascular pharmacology 67 (6), 544-551, 2016 | 122 | 2016 |
Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ... Diabetes Care 40 (12), 1733-1738, 2017 | 120 | 2017 |
2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set … MM Kittleson, GS Panjrath, K Amancherla, LL Davis, A Deswal, DL Dixon, ... Journal of the American College of Cardiology 81 (18), 1835-1878, 2023 | 119 | 2023 |
Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week BS Wiggins, DL Dixon, RR Neyens, RL Page, TJ Gluckman Journal of the American College of Cardiology 75 (11), 1341-1350, 2020 | 118 | 2020 |
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2) BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ... Clinical cardiology 40 (9), 626-632, 2017 | 116 | 2017 |
Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist JD Bucheit, LG Pamulapati, N Carter, K Malloy, DL Dixon, EM Sisson Diabetes technology & therapeutics 22 (1), 10-18, 2020 | 101 | 2020 |
Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ... Basic to Translational Science 2 (5), 513-525, 2017 | 98 | 2017 |
Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension N Fatani, DL Dixon, BW Van Tassell, J Fanikos, LF Buckley Journal of the American College of Cardiology 77 (10), 1290-1299, 2021 | 81 | 2021 |
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient MK Cheeley, JJ Saseen, A Agarwala, S Ravilla, N Ciffone, TA Jacobson, ... Journal of Clinical Lipidology 16 (4), 361-375, 2022 | 80 | 2022 |
Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19) DL Dixon, BW Van Tassell, A Vecchié, A Bonaventura, AH Talasaz, ... Journal of cardiovascular pharmacology 75 (5), 359-367, 2020 | 69 | 2020 |
Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review SL Littauer, DL Dixon, VK Mishra, EM Sisson, TM Salgado Pharmacy Practice (Granada) 15 (4), 2017 | 66 | 2017 |
Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation M Trivedi, J Jee, S Silva, C Blomgren, VM Pontinha, DL Dixon, ... Additive Manufacturing 23, 319-328, 2018 | 64 | 2018 |